Literature DB >> 12352620

Preferential expression of IGF-I in small DRG neurons and down-regulation following injury.

Matthew J Craner1, Joshua P Klein, Joel A Black, Stephen G Waxman.   

Abstract

In this study, we examined the expression of insulin-like growth factor I (IGF-I) and its receptor (IGF-IR) in dorsal root ganglia (DRG) neurons in two rodent models of nerve injury: sciatic nerve axotomy and streptozotocin-induced (STZ) painful diabetic neuropathy. We demonstrate that IGF-I and its receptor are preferentially expressed in small (< 25 microm diameter) DRG neurons. There is a significant down-regulation in the expression of IGF-I and IGF-IR in the small DRG neurons of STZ rats by 59% and 71%, respectively. A parallel reduction in expression is shown in axotomized < 25 microm diameter DRG neurons for IGF-I (47%) but not for IGF-IR. The loss of IGF-I support to a population of predominantly nociceptive neurons may contribute to neuropathic pain observed in these models.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352620     DOI: 10.1097/00001756-200209160-00016

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Maladaptive dendritic spine remodeling contributes to diabetic neuropathic pain.

Authors:  Andrew M Tan; Omar A Samad; Tanya Z Fischer; Peng Zhao; Anna-Karin Persson; Stephen G Waxman
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

2.  Regulatory effects of insulin-like growth factor-1 on the expression of sensory neuropeptide mRNAs in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate.

Authors:  Hui-Cui Gong; Xiang-Dong Yang; Zhen Liu; Zi-Ying Xing; Huai-Jing Wang; Zhen-Zhong Li
Journal:  Neurosci Bull       Date:  2010-04       Impact factor: 5.203

Review 3.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

Review 4.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

5.  Bisphenol A Represses Dopaminergic Neuron Differentiation from Human Embryonic Stem Cells through Downregulating the Expression of Insulin-like Growth Factor 1.

Authors:  Boxian Huang; Song Ning; Qinjing Zhang; Aiqin Chen; Chunyan Jiang; Yugui Cui; Jian Hu; Hong Li; Guoping Fan; Lianju Qin; Jiayin Liu
Journal:  Mol Neurobiol       Date:  2016-06-07       Impact factor: 5.590

6.  Activation of ERK1/2 and PI3K/Akt by IGF-1 on GAP-43 expression in DRG neurons with excitotoxicity induced by glutamate in vitro.

Authors:  Zhen Liu; Heng Cai; Ping Zhang; Hao Li; Huaxiang Liu; Zhenzhong Li
Journal:  Cell Mol Neurobiol       Date:  2011-08-06       Impact factor: 5.046

7.  Insulin-like growth factor-1 prevents dorsal root ganglion neuronal tyrosine kinase receptor expression alterations induced by dideoxycytidine in vitro.

Authors:  Huaxiang Liu; Jing Lu; Yong He; Bin Yuan; Yizhao Li; Xingfu Li
Journal:  Cell Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.046

8.  Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.

Authors:  José M Garcia; Juan P Cata; Patrick M Dougherty; Roy G Smith
Journal:  Endocrinology       Date:  2007-10-25       Impact factor: 4.736

Review 9.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

10.  Remote neurotrophic support of epidermal nerve fibres in experimental diabetes.

Authors:  C Toth; V Brussee; D W Zochodne
Journal:  Diabetologia       Date:  2006-03-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.